Neurocrine Biosciences Appoints Samir Siddhanti Chief Business Officer
PR Newswire
SAN DIEGO, July 21, 2026
SAN DIEGO, July 21, 2026 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the appointment of Samir Siddhanti as Chief Business Officer and a member of the company's executive Management Committee.
View original content to download multimedia:https://www.prnewswire.com/news-releases/neurocrine-biosciences-appoints-samir-siddhanti-chief-business-officer-302830875.htmlSOURCE Neurocrine Biosciences, Inc.
